Page last updated: 2024-08-20

diphenhydramine hydrochloride and Graft-Versus-Host Disease

diphenhydramine hydrochloride has been researched along with Graft-Versus-Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Morice, AH; Sadofsky, LR; Sykes, DL; Zhang, M1

Reviews

1 review(s) available for diphenhydramine hydrochloride and Graft-Versus-Host Disease

ArticleYear
ATP, an attractive target for the treatment of refractory chronic cough.
    Purinergic signalling, 2022, Volume: 18, Issue:3

    Topics: Adenosine Triphosphate; Antitussive Agents; Chronic Disease; Cough; Graft vs Host Disease; Humans; Treatment Outcome

2022